✦ LIBER ✦

CLINICAL OUTCOMES FOLLOWING GLYCOPROTEIN 2B/3A INHIBITION IN PCI FOR ACUTE CORONARY SYNDROME: INSIGHTS FROM THE NCDR®

✍ Scribed by Safley, David M.; Venkitachalam, Lakshmi; kennedy, Kevin; Cohen, David

Book ID: 122390888
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 160 KB
Volume: 61
Category: Article
ISSN: 1558-3597
DOI: 10.1016/S0735-1097(13)61916-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Promise of combined low-molecular-weight

Promise of combined low-molecular-weight heparin and platelet glycoprotein IIb/IIIa inhibition: Results from Platelet IIb/IIIa Antagonist for the Reduction of Acute coronary syndrome events in a Global Organization Network B (PARAGON B)

✍ Debabrata Mukherjee; Kenneth W. Mahaffey; David J. Moliterno; Robert A. Harringt 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 120 KB

Cystatin C- and Creatinine-Based Estimat

Cystatin C- and Creatinine-Based Estimates of Renal Function and Their Value for Risk Prediction in Patients with Acute Coronary Syndrome: Results from the PLATelet Inhibition and Patient Outcomes (PLATO) Study

✍ Akerblom, A.; Wallentin, L.; Larsson, A.; Siegbahn, A.; Becker, R. C.; Budaj, A. 📂 Article 📅 2013 🏛 American Association for Clinical Chemistry 🌐 English ⚖ 615 KB